The American journal of cardiology (Am J Cardiol)

Journal PubWeight™ 22853.79‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. 1986 18.40
2 Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. 2007 9.62
3 The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. 2004 9.43
4 Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. 1987 9.10
5 Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. 1994 7.21
6 Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. 1976 6.84
7 Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. 1998 6.76
8 Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. 1967 6.74
9 Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) 1998 6.48
10 A more meaningful scoring system for determining the severity of coronary heart disease. 1983 6.27
11 Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. 2004 5.82
12 Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). 2003 5.77
13 Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. 2002 5.74
14 Sinus of Valsalva aneurysms--47 years of a single center experience and systematic overview of published reports. 2007 5.71
15 A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). 1989 5.50
16 Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. 2011 5.46
17 Role of diabetes in congestive heart failure: the Framingham study. 1974 5.11
18 A general cardiovascular risk profile: the Framingham Study. 1976 5.10
19 Quadricuspid semilunar valve. 1973 5.07
20 Natural history of angina pectoris in the Framingham study. Prognosis and survival. 1972 5.05
21 Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. 1971 4.90
22 New type of cardiomyopathy associated with diabetic glomerulosclerosis. 1972 4.86
23 Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. 1995 4.83
24 Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). 2008 4.83
25 Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 2007 4.78
26 Frequency of primary tumors of the heart. 1996 4.70
27 Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. 1989 4.69
28 Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. 2002 4.56
29 Bedside technics for the evaluation of ventricular function in man. 1969 4.33
30 Incidence, description and functional assessment of isolated quadricuspid aortic valves. 1990 4.33
31 Unwanted effects of propranolol. 1966 4.33
32 Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. 1987 4.27
33 Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. 2010 4.27
34 Two-dimensional echocardiographic aortic root dimensions in normal children and adults. 1989 4.27
35 Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 2007 4.21
36 The anatomy of common aorticopulmonary trunk (truncus arteriosus communis) and its embryologic implications. A study of 57 necropsy cases. 1965 4.16
37 The developmental complex of "parachute mitral valve," supravalvular ring of left atrium, subaortic stenosis, and coarctation of aorta. 1963 4.15
38 Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 2007 4.14
39 Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. 1990 4.10
40 Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). 1994 4.08
41 The pharmacology of beta sympathetic blockade. 1966 3.96
42 Heart failure from the point of view of quantitative anatomy. 1960 3.89
43 Comparison of alternating current with direct electroshock across the closed chest. 1962 3.88
44 The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. 2005 3.85
45 From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. 2006 3.82
46 Primary and secondary neoplasms of the heart. 1997 3.79
47 Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. 1966 3.77
48 Congenital heart disease in a cohort of 19,502 births with long-term follow-up. 1978 3.73
49 Problems in evaluating coronary care units. Their responsibilities and their relation to the community. 1967 3.70
50 The congenitally bicuspid aortic valve. A study of 85 autopsy cases. 1970 3.69
Next 50